We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Generic Line interviewed Bruce Downey, chairman and CEO of Barr Pharmaceuticals, a specialty company engaged in the development, manufacture and marketing of proprietary and generic prescription pharmaceuticals.
With the U.S. facing a severe shortage of flu shots this season, the Generic Pharmaceutical Association (GPhA) has renewed its call for the FDA and Congress to move forward to accelerate the approval of affordable generic vaccines.
Beginning a regular look at generic industry leaders and their opinions on key issues, Generic Line interviewed Kathleen Jaeger, president and CEO of the Generic Pharmaceutical Association (GPhA).